Human KIR Antibody (Lirilumab, Research Use)

产品名称	Human KIR Antibody (Lirilumab, Research Use)
目录号	NBR-0056
别名	KIR3DL1; NKB1; CD158E1; NKB1B 2; CD158e1/2
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0056-100UG	100ug	￥550	请咨询
NBR-0056-1MG	1mg	￥3500	请咨询
NBR-0056-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human KIR Antibody (Lirilumab, Research Use)
产品编号：NBR-0056
针对靶点：KIR
抗体药商品名：Lirilumab
抗体药描述：Lirilumab (INN) is a human monoclonal antibody designed for the treatment of cancer.[It binds to KIR2DL1/2L3.This drug was developed by Innate Pharma and is licensed to Bristol-Myers Squibb.A phase 2 clinical trial for acute myeloid leukemia (AML) was terminated early ("failed") in 2017.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: KIR
Synonyms: KIR3DL1; NKB1; CD158E1; NKB1B 2; CD158e1/2
Target Description: Receptor on natural killer (NK) cells for some HLA-C alleles such as w4 and w6. Inhibits the activity of NK cells thus preventing cell lysis.
Ensembl: ENSG00000167633
Uniprot: P43629